Viewing Study NCT00535951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-04 @ 7:47 PM
Study NCT ID: NCT00535951
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2007-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
None Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None NSCLC View
None lung cancer View
None pleural mesothelioma View
None malignant View
None advanced stage View
None mesothelioma View
None phase I View
None LBH589 View
None dextromethorphan View
None CYP2D6 View
None oral View